Granisetron, a 5-HT3 receptor antagonist, inhibited cisplatin-induced 5-hydroxytryptamine release in the isolated ileum of ferrets

被引:0
|
作者
Endo, T
Ogawa, T
Hamaue, N
Akita, K
Hirafuji, M
Minami, M [1 ]
Blower, PR
机构
[1] Hlth Sci Univ Hokkaido, Fac Pharmaceut Sci, Dept Pharmacol, Ishikari, Hokkaido 0610293, Japan
[2] SmithKline Beecham Pharmaceut, Strateg Prod Dev, Harlow CM19 5AW, Essex, England
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We investigated the influence of granisetron, a 5-HT3 receptor antagonist, on the increase in 5-hydroxytryptamine (5-HT) release induced by cisplatin from the isolated ileum of the ferret, a species known to vomit in response to cisplatin. 2-Methyl-5-MT, a selective 5-HT, receptor agonist, increased the release of 5-HT from the ferret ileum in a concentration-dependent manner within the range of 10(-7) to 10(-6) M . The 5-HT release induced by 2-methyl-5-HT was significantly inhibited by a concomitant perfusion with granisetron (10(-6) M). Cisplatin also increased the 5-HT release from the ferret ileum within the range of 10(-8) to 10(-6) M, in a concentration-dependent manner. Granisetron (10(-6) M) also significantly inhibited the cisplatin-induced 5-HT release. Since the cisplatin-induced 5-HT release was significantly inhibited by tetrodotoxin, the possible involvement of an interneuron pathway in the cisplatin-induced 5-HT release mechanism was suggested in the ileal tissue. It is likely that granisetron inhibited the cisplatin-induced 5-HT release from the gut EC cells by producing blockade of an EC cell 5-HT3 receptor.
引用
收藏
页码:243 / 253
页数:11
相关论文
共 50 条
  • [1] EMESIS AND DEFECATIONS INDUCED BY THE 5-HYDROXYTRYPTAMINE (5-HT3) RECEPTOR ANTAGONIST ZACOPRIDE IN THE FERRET
    KING, GL
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1990, 253 (03): : 1034 - 1041
  • [2] Repeated administration of the 5-HT3 receptor antagonist granisetron reduces the incidence of delayed cisplatin-induced emesis in the piglet
    Grelot, L
    LeStunff, H
    Milano, S
    Blower, PR
    Romain, D
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 279 (01): : 255 - 261
  • [3] 5-hydroxytryptamine (5-HT) concentration in cisplatin-induced emesis
    Minami, Masaru
    Liu, Yanxia
    Endo, Toru
    Hiafuji, Masahiko
    Hamaue, Naoya
    Saito, Hideya
    Parvez, Hasan S.
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 101 : 120 - 120
  • [4] 5-hydroxytryptamine type 3 (5-HT3) antagonist, granisetron, reverses secretion in human cholera model.
    Turvill, JL
    Mourad, FH
    Farthing, MJG
    GASTROENTEROLOGY, 1996, 110 (04) : A368 - A368
  • [5] The inhibition of cholera toxin-induced 5-HT release by the 5-HT3 receptor antagonist, granisetron, in the rat
    Turvill, JL
    Connor, P
    Farthing, MJG
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (05) : 1031 - 1036
  • [6] The effects of nabumetone, a cyclooxygenase-2 inhibitor, on cisplatin-induced 5-hydroxytryptamine release from the isolated rat ileum
    Kudo, C
    Minami, M
    Hirafuji, M
    Endo, T
    Hamaue, N
    Akita, K
    Murakami, T
    Kawaguchi, H
    RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY, 2001, 110 (1-2) : 117 - 132
  • [7] 5-HT3 receptors are not involved in conditioned taste aversions induced by 5-hydroxytryptamine, ipecacuanha or cisplatin
    Rudd, JA
    Ngan, MP
    Wai, MK
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 352 (2-3) : 143 - 149
  • [8] Effects of SB204070, a new 5-HT4 receptor antagonist, on 5-hydroxytryptamine release from the isolated ileum of the ferret
    Endo, T
    Teramoto, Y
    Hamaue, N
    Hirafuji, M
    Monma, Y
    Minami, M
    Blower, PR
    BIOGENIC AMINES, 1998, 14 (06) : 645 - 654
  • [9] Effects of metformin on intestinal 5-hydroxytryptamine (5-HT) release and on 5-HT3 receptors
    Cubeddu, LX
    Bönisch, H
    Göthert, M
    Molderings, G
    Racké, K
    Ramadori, G
    Miller, KJ
    Schwörer, H
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2000, 361 (01) : 85 - 91
  • [10] Effects of metformin on intestinal 5-hydroxytryptamine (5-HT) release and on 5-HT3 receptors
    L.X. Cubeddu
    H. Bönisch
    M. Göthert
    G. Molderings
    K. Racké
    G. Ramadori
    K.J. Miller
    H. Schwörer
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2000, 361 : 85 - 91